{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:18:22Z","timestamp":1792520302195,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM119679"],"award-info":[{"award-number":["R35GM119679"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2020,1,2]]},"DOI":"10.1038\/s41565-019-0600-1","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T12:03:00Z","timestamp":1578312180000},"page":"41-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":279,"title":["Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis"],"prefix":"10.1038","volume":"15","author":[{"given":"Xucheng","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5544-1522","authenticated-orcid":false,"given":"Xinfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"McComb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5786-0659","authenticated-orcid":false,"given":"Yizhou","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"600_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart, K. et al. Recognizing sepsis as a global health priority\u2014a WHO resolution. N. Engl. J. Med. 377, 414\u2013417 (2017).","journal-title":"N. Engl. J. Med."},{"key":"600_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1473-3099(01)00093-7","volume":"1","author":"T van der Poll","year":"2001","unstructured":"van der Poll, T. Immunotherapy of sepsis. Lancet Infect. Dis. 1, 165\u2013174 (2001).","journal-title":"Lancet Infect. Dis."},{"key":"600_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jinf.2011.08.004","volume":"63","author":"R Huttunen","year":"2011","unstructured":"Huttunen, R. & Aittoniemi, J. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J. Infect. 63, 407\u2013419 (2011).","journal-title":"J. Infect."},{"key":"600_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss, R. S. & Karl, I. E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138\u2013150 (2003).","journal-title":"N. Engl. J. Med."},{"key":"600_CR5","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1186\/cc10332","volume":"15","author":"GP Otto","year":"2011","unstructured":"Otto, G. P. et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care 15, R183 (2011).","journal-title":"Crit. Care"},{"key":"600_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R. S., Monneret, G. & Payen, D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13, 260\u2013268 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"600_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/10512","volume":"5","author":"BJ Czermak","year":"1999","unstructured":"Czermak, B. J. et al. Protective effects of C5a blockade in sepsis. Nat. Med. 5, 788\u2013792 (1999).","journal-title":"Nat. Med."},{"key":"600_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/JLB.4MIR1118-425R","volume":"106","author":"PA Ward","year":"2019","unstructured":"Ward, P. A. & Fattahi, F. New strategies for treatment of infectious sepsis. J. Leukoc. Biol. 106, 187\u2013192 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"600_CR9","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1073\/pnas.0809422106","volume":"106","author":"X Huang","year":"2009","unstructured":"Huang, X. et al. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl Acad. Sci. USA 106, 6303\u20136308 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"600_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm0697-678","volume":"3","author":"WD Docke","year":"1997","unstructured":"Docke, W. D. et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3, 678\u2013681 (1997).","journal-title":"Nat. Med."},{"key":"600_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1164\/rccm.2009005","volume":"166","author":"JJ Presneill","year":"2002","unstructured":"Presneill, J. J., Harris, T., Stewart, A. G., Cade, J. F. & Wilson, J. W. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am. J. Respir. Crit. Care Med. 166, 138\u2013143 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"600_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/sur.2015.245","volume":"17","author":"N Galbraith","year":"2016","unstructured":"Galbraith, N., Walker, S., Galandiuk, S., Gardner, S. & Polk, H. C. Jr The significance and challenges of monocyte impairment: for the ill patient and the surgeon. Surg. Infect. 17, 303\u2013312 (2016).","journal-title":"Surg. Infect."},{"key":"600_CR13","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1186\/cc10031","volume":"15","author":"L Bo","year":"2011","unstructured":"Bo, L., Wang, F., Zhu, J., Li, J. & Deng, X. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit. Care 15, R58 (2011).","journal-title":"Crit. Care"},{"key":"600_CR14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/nrmicro1289","volume":"3","author":"TJ Foster","year":"2005","unstructured":"Foster, T. J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3, 948\u2013958 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"600_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tim.2008.11.005","volume":"17","author":"C Garzoni","year":"2009","unstructured":"Garzoni, C. & Kelley, W. L. Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol. 17, 59\u201365 (2009).","journal-title":"Trends Microbiol."},{"key":"600_CR16","doi-asserted-by":"publisher","first-page":"UTI-0026-2016","DOI":"10.1128\/microbiolspec.UTI-0026-2016","volume":"4","author":"AJ Lewis","year":"2016","unstructured":"Lewis, A. J., Richards, A. C. & Mulvey, M. A. Invasion of host cells and tissues by uropathogenic bacteria. Microbiol. Spectr. 4, UTI-0026-2016 (2016).","journal-title":"Microbiol. Spectr."},{"key":"600_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.it.2017.03.006","volume":"38","author":"AM Pauwels","year":"2017","unstructured":"Pauwels, A. M., Trost, M., Beyaert, R. & Hoffmann, E. Patterns, receptors, and signals: regulation of phagosome maturation. Trends Immunol. 38, 407\u2013422 (2017).","journal-title":"Trends Immunol."},{"key":"600_CR18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1517\/13543784.11.8.1161","volume":"11","author":"FJ Giles","year":"2002","unstructured":"Giles, F. J., Redman, R., Yazji, S. & Bellm, L. Iseganan HCl: a novel antimicrobial agent. Expert Opin. Investig. Drugs 11, 1161\u20131170 (2002).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"600_CR19","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1242\/jcs.00184","volume":"115","author":"M Linke","year":"2002","unstructured":"Linke, M., Herzog, V. & Brix, K. Trafficking of lysosomal cathepsin B-green fluorescent protein to the surface of thyroid epithelial cells involves the endosomal\/lysosomal compartment. J. Cell Sci. 115, 4877\u20134889 (2002).","journal-title":"J. Cell Sci."},{"key":"600_CR20","unstructured":"Vasey, P. A. et al. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents\u2013drug-polymer conjugates. Clin. Cancer Res. 5, 83\u201394 (1999)."},{"key":"600_CR21","doi-asserted-by":"crossref","unstructured":"Frimodt-M\u00f8ller, N., Knudsen, J. & Espersen, F. in Handbook of Animal Models of Infection 127\u2013136 (1999).","DOI":"10.1016\/B978-012775390-4\/50153-6"},{"key":"600_CR22","doi-asserted-by":"publisher","first-page":"e1003959","DOI":"10.1371\/journal.ppat.1003959","volume":"10","author":"G McVicker","year":"2014","unstructured":"McVicker, G. et al. Clonal expansion during Staphylococcus aureus infection dynamics reveals the effect of antibiotic intervention. PLoS Pathog. 10, e1003959 (2014).","journal-title":"PLoS Pathog."},{"key":"600_CR23","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.cell.2019.05.043","volume":"177","author":"D Crow","year":"2019","unstructured":"Crow, D. Could iPSCs enable \u201coff-the-shelf\u201d cell therapy? Cell 177, 1667\u20131669 (2019).","journal-title":"Cell"},{"key":"600_CR24","first-page":"e50323","volume":"76","author":"W Ying","year":"2013","unstructured":"Ying, W., Cheruku, P. S., Bazer, F. W., Safe, S. H. & Zhou, B. Investigation of macrophage polarization using bone marrow derived macrophages. J. Vis. Exp. 76, e50323 (2013).","journal-title":"J. Vis. Exp."},{"key":"600_CR25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s12274-019-2308-9","volume":"12","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer. Nano Res. 12, 855\u2013861 (2019).","journal-title":"Nano Res."},{"key":"600_CR26","doi-asserted-by":"publisher","first-page":"8099","DOI":"10.1021\/acs.nanolett.5b03528","volume":"15","author":"B Li","year":"2015","unstructured":"Li, B. et al. An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo. Nano Lett. 15, 8099\u20138107 (2015).","journal-title":"Nano Lett."},{"key":"600_CR27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1021\/mp100390w","volume":"8","author":"X Su","year":"2011","unstructured":"Su, X., Fricke, J., Kavanagh, D. G. & Irvine, D. J. In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. Mol. Pharm. 8, 774\u2013787 (2011).","journal-title":"Mol. Pharm."},{"key":"600_CR28","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1073\/pnas.0609370104","volume":"104","author":"L Zhang","year":"2007","unstructured":"Zhang, L. et al. High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc. Natl Acad. Sci. USA 104, 4606\u20134611 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"}],"updated-by":[{"DOI":"10.1038\/s41565-020-0675-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000}}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41565-019-0600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41565-019-0600-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41565-019-0600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:58:44Z","timestamp":1684605524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-019-0600-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,2]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1038\/s41565-019-0600-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737164151.793569527","asserted-by":"object"}]},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"8 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41565-020-0675-8","URL":"https:\/\/doi.org\/10.1038\/s41565-020-0675-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}